Drug Pipeline

Hydrochlorothiazide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
1
Phase 3
4
Top Sponsors
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-05-18 NCT07593612 TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart Failure Phase 4 Not Yet Recruiting
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07593612 TACTIC-HF: Sequential Diuretic Strategies in Ambulatory Worsening Heart Failure Acute Heart Failure (AHF) Not Yet Recruiting
Phase 3
NCT05373264 HYDROchlorothiazide to PROTECT Polycystic Kidney Disease Patients and Improve Their… ADPKD Recruiting
Phase 2
NCT06111885 Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention Kidney Stone Recruiting
Not specified
NCT03511118 Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed… Lactating Women on Select DOI Recruiting
Sponsors Running Hydrochlorothiazide Trials
Duke University (1) University Medical Center Groningen (1) Insel Gruppe AG, University Hospital Bern (1) Lucrecia Maria Burgos (1)
Disease Areas
Heart Failure (1)
Get alerts when Hydrochlorothiazide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free